miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes

Mohammad Shahidul Makki1, Tariq M Haqqi1

  • 1Department of Anatomy and Neurobiology, Northeast Ohio Medical University, Rootstown, OH USA.

Insights

MicroRNA-139 (miR-139) promotes osteoarthritis by downregulating MCPIP1, increasing inflammatory IL-6. Targeting miR-139 may offer a new therapeutic strategy for osteoarthritis management.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Osteoarthritis (OA) pathogenesis involves interleukin-6 (IL-6) overexpression.
  • MCPIP1 regulates IL-6 expression post-transcriptionally.
  • The 3' untranslated region (UTR) of MCPIP1 mRNA contains a miR-139 binding site.

Purpose of the Study:

  • To investigate the post-transcriptional regulation of MCPIP1 by miR-139.
  • To determine the impact of miR-139 on IL-6 expression in OA chondrocytes.
  • To explore the therapeutic potential of targeting miR-139 in OA.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure gene and microRNA expression.
  • Western blotting to assess protein levels.
  • Luciferase reporter assays to confirm direct interaction between miR-139 and MCPIP1 3' UTR.
  • Cell viability and apoptosis assays.

Main Results:

  • miR-139 expression was elevated in OA cartilage and induced by IL-1β.
  • Inhibition of miR-139 decreased IL-6 mRNA and protein levels, while overexpression increased them.
  • miR-139 directly targeted MCPIP1 mRNA, reducing MCPIP1 expression.
  • Overexpression of miR-139 promoted catabolic gene expression, induced apoptosis, and increased IL-6 levels, which in turn upregulated miR-139.

Conclusions:

  • miR-139 acts as a post-transcriptional regulator of MCPIP1, enhancing IL-6 expression in OA chondrocytes.
  • The miR-139/MCPIP1/IL-6 axis plays a crucial role in OA pathogenesis.
  • Targeting miR-139 represents a potential therapeutic strategy for managing osteoarthritis.